SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-018541
Filing Date
2023-03-08
Accepted
2023-03-08 16:10:37
Documents
4
Effectiveness Date
2023-03-08

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea174828-s8_protara.htm S-8 113788
2 OPINION OF SULLIVAN & CROMWELL LLP ea174828ex5-1_protara.htm EX-5.1 5417
3 CONSENT OF ERNST & YOUNG LLP ea174828ex23-1_protara.htm EX-23.1 3439
4 FILING FEE TABLE ea174828ex-fee_protara.htm EX-FILING FEES 25303
  Complete submission text file 0001213900-23-018541.txt   149155
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270354 | Film No.: 23716238
SIC: 2836 Biological Products, (No Diagnostic Substances)